Bioxyne Ltd (BXN) - Financial and Strategic SWOT Analysis Review

November 2021 | 34 pages | ID: B4F90C429A9EN
GlobalData

Abstracts

Bioxyne Ltd (BXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bioxyne Ltd (Bioxyne) is a biotechnology company that develops, manufactures, markets, and commercializes healthcare products in the areas of immune health and immunotherapeutics. It manufactures consumer food supplements such as, ProTract and Progastrim, which are based on a proprietary probiotic strain PCC (lactobacillus fermentum). It also develops a range of existing functional food and beauty products containing ingredients sourced from New Zealand. The company caters to consumer dietary supplements and functional foods markets. Its products are used as dietary supplement, foodstuffs and beverages. The company has manufacturing and distribution agreements with Chr. Hansen and Nu-Skin Enterprises. Bioxyne is headquartered in Sydney, New South Wales, Australia.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Bioxyne Ltd - Key Facts
Bioxyne Ltd - Key Employees
Bioxyne Ltd - Key Employee Biographies
Bioxyne Ltd - Major Products and Services
Bioxyne Ltd - History
Bioxyne Ltd - Company Statement
Bioxyne Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Bioxyne Ltd - Business Description
Business Segment: Direct Sales
Performance
Business Segment: Wholesale Sales
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Australia and New Zealand
Performance
Geographical Segment: The US
Performance
Bioxyne Ltd - SWOT Analysis
SWOT Analysis - Overview
Bioxyne Ltd - Strengths
Bioxyne Ltd - Weaknesses
Bioxyne Ltd - Opportunities
Bioxyne Ltd - Threats
Bioxyne Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Bioxyne Ltd, Recent Deals Summary

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Bioxyne Ltd, Key Facts
Bioxyne Ltd, Key Employees
Bioxyne Ltd, Key Employee Biographies
Bioxyne Ltd, Major Products and Services
Bioxyne Ltd, History
Bioxyne Ltd, Subsidiaries
Bioxyne Ltd, Key Competitors
Bioxyne Ltd, Ratios based on current share price
Bioxyne Ltd, Annual Ratios
Bioxyne Ltd, Annual Ratios (Cont...1)
Bioxyne Ltd, Annual Ratios (Cont...2)
Bioxyne Ltd, Interim Ratios
Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Bioxyne Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Bioxyne Ltd, Performance Chart (2017 - 2021)
Bioxyne Ltd, Ratio Charts
Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Bioxyne Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021